Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 2, 2009, Pages 337-344

  Bolignano, Davide ^a   Lacquaniti, Antonio ^a   Coppolino, Giuseppe ^a   Donato, Valentina ^a   Campo, Susanna ^a   Fazio, Maria Rosaria ^a   Nicocia, Giacomo ^a   Buemi, Michele ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CALCIUM; CREATININE; FIBRINOGEN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PHOSPHATE BINDING AGENT; URIC ACID; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ADULT; AGE; ARTICLE; BLOOD ANALYSIS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROPORTIONAL HAZARDS MODEL; PROTEINURIA; URINALYSIS; AGED; BLOOD; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; KAPLAN MEIER METHOD; KIDNEY DISEASE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; ROC CURVE; URINE;

ACUTE-PHASE PROTEINS; ADULT; AGED; BIOLOGICAL MARKERS; CHRONIC DISEASE; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; LIPOCALINS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE;

EID: 66849091695     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03530708     Document Type: Article

References (30)

1. Kent DM, Jafar TH, Hayward RA, Tighiouart H, Landa M, de Jong P, de Zeeuw D, Remuzzi G, Kamper AL, Levey AS: Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in non-diabetic kidney disease. J Am Soc Nephrol 18: 1959-1965, 2007
2. Hunsicker LG, Adler S, Caggiula A, England BK, Greene T, Kusek JW, Rogers NL, Teschan PE: Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 51: 1908-1919, 1997
3. Eddy AA, Neilson EG. Chronic kidney disease progression: J Am Soc Nephrol 17:2964-2966, 2006
4. Phillips AO: The role of renal proximal tubular cells in diabetic nephropathy. Curr Diab Rep 3: 491-496, 2003 (Pubitemid 38906810)
5. Bruzzi I, Remuzzi G, Benigni A: Endothelin: A mediator of renal disease progression. J Nephrol 10: 179-183, 1997 (Pubitemid 27333192)
6. Hofstra JM, Deegens JK, Willems HL, Wetzels JF: Beta-2- microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy. Nephrol Dial Transplant 23: 2546-2551, 2008
7. Kamijo A, Sugaya T, Hikawa A, Yamanouchi M, Hirata Y, Ishimitsu T, Numabe A, Takagi M, Hayakawa H, Tabei F, Sugimoto T, Mise N, Kimura K: Clinical evaluation of urinary excretion of liver-type fatty acid-binding protein as a marker for the monitoring of chronic kidney disease: A multicenter trial. J Lab Clin Med 145: 125-133, 2005
8. Bolignano D, Coppolino G, Lacquaniti A, Nicocia G, Buemi M: Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin (NGAL) in macroprotein-uric patients with worsening renal function. Kidney Blood Press Res 31: 274-279, 2008
9. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
10. Rossing P: Doubling of serum creatinine: Is it sensitive and relevant? Nephrol Dial Transplant 13: 244-246, 1998
11. United States Renal Data System: Annual Report of the US Renal Data System 2007. National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. 2007
12. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007 (Pubitemid 350074801)
13. Zoccali C: The burden of cardiovascular disease in patients with chronic kidney disease and in end-stage renal disease. Contrib Nephrol 161: 63-67, 2008
14. Neugarten J, Acharya A, Silbiger SR: Effect of gender on the progression of nondiabetic renal disease: A meta-analysis. J Am Soc Nephrol 11: 319-329. 2000 (Pubitemid 30064855)
15. Jafar TH, Schmid CH, Stark PC, Toto R, Remuzzi G, Ruggenenti P, Marcantoni C, Becker G, Shahinfar S, De Jong PE, De Zeeuw D, Kamper AL, Strangaard S, Levey AS: The rate of progression of renal disease may not be slower in women compared with men: A patient-level meta-analysis. Nephrol Dial Transplant 18: 2047-2053, 2003
16. Schwarz S, Trivedi BK, Kalantar-Zadeh K, Kovesdy CP: Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol 1: 825-831, 2006
17. Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F; MMKD Study Group, Kuen E, König P, Kraatz G, Mann JF, Müller GA, Köhler H, Riegler P: Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 18: 2600-2608, 2007
18. Boes E, Fliser D, Ritz E, König P, Lhotta K, Mann JF, Müller GA, Neyer U, Riegel W, Riegler P, Kronenberg F: Apolipoprotein A-IV predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. J Am Soc Nephrol 17: 528-536, 2006
19. Ravani P, Tripepi G, Malberti F, Testa S, Mallamaci F, Zoccali C: Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: A competing risks modeling approach. J Am Soc Nephrol 16: 2449-2455, 2005 (Pubitemid 41725063)
20. Fliser D, Kronenberg F, Kielstein JT, Morath C, Bode-Böger SM, Haller H, Ritz E: Asymmetric dimethylarginine and progression of chronic kidney disease: The Mild to Moderate Kidney Disease Study. J Am Soc Nephrol 16: 2456-2461, 2005 (Pubitemid 41725064)
21. Bolignano D, Donato V, Coppolino G, Campo C, Buemi A, Lacquaniti A, Buemi M: Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis 52: 595-609, 2008
22. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365: 1231-1238, 2005 (Pubitemid 40469655)
23. Hirsch R, Dent C, Pfriem H, Allen J, Beekman RH 3rd, Ma Q, Dastrala S, Bennett M, Mitsnefes M, Devarajan P: NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol 22: 2089-2095, 2007
24. Ling W, Zhaohui N, Ben H, Leyi G, Jianping L, Huili D, Jiaqi Q: Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Nephron Clin Pract 108: c176-c181, 2008 (Pubitemid 351588109)
25. Wheeler DS, Devarajan P, Ma Q, Harmon K, Monaco M, Cvijanovich N, Wong HR: Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med 36: 1297-1303, 2008
26. Parikh CR, Jani A, Mishra J, Ma Q, Kelly C, Barasch J, Edelstein CL, Devarajan P: Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 6: 1639-1645, 2006 (Pubitemid 43945804)
27. Bolignano D, Coppolino G, Campo S, Aloisi C, Nicocia G, Frisina N, Buemi M: Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients. Nephrol Dial Transplant 23: 414-416, 2008 (Pubitemid 351767366)
28. Bolignano D, Coppolino G, Campo S, Aloisi C, Nicocia G, Frisina N, Buemi M: Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. Am J Nephrol 27: 373-378, 2007 (Pubitemid 47077201)
29. Bolignano D, Lacquaniti A, Coppolino G, Campo S, Arena A, Buemi M: Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease. Kidney Blood Press Res 31: 255-258, 2008
30. Mori K, Nakao K: Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int 71: 967-970, 2007 (Pubitemid 46741985)